Literature DB >> 10623470

Nuclear translocation of a leukocyte elastase Inhibitor/Elastase complex during staurosporine-induced apoptosis: role in the generation of nuclear L-DNase II activity.

C A Belmokhtar1, A Torriglia, M F Counis, Y Courtois, A Jacquemin-Sablon, E Ségal-Bendirdjian.   

Abstract

Using L1210 murine leukemia cells, we have previously shown that in response to treatment with drugs having different targets, apoptotic cell death occurs through at least two different signaling pathways. Here, we present evidence that nuclear extracts from staurosporine-treated cells elicit DNase II activity that is not detected in nuclear extracts from cisplatin-treated cells. This activity correlates with the accumulation of two nuclear proteins (70 and 30 kDa) which are detected by an anti-L-DNase II antibody. Partial purification of this DNase II activity suggests that the 30-kDa protein could be the nuclease responsible for staurosporine-induced DNA fragmentation. The 70-kDa protein is also recognized by an anti-elastase antibody, suggesting that it carries residues belonging to both L-DNase II and elastase. Since previous findings showed that L-DNase II was generated from the leukocyte inhibitor of elastase, we propose that the 70-kDa protein results from an SDS-stable association between these two proteins and is translocated from the cytoplasm to the nucleus during staurosporine-induced apoptosis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623470     DOI: 10.1006/excr.1999.4737

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Conformational modification of serpins transforms leukocyte elastase inhibitor into an endonuclease involved in apoptosis.

Authors:  Laura Padron-Barthe; Chloé Leprêtre; Elisabeth Martin; Marie-France Counis; Alicia Torriglia
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

2.  α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation.

Authors:  Subhasree Basu; Suren Rajakaruna; Adèle De Arcangelis; Liping Zhang; Elisabeth Georges-Labouesse; A Sue Menko
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

Review 3.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

4.  The role of GSH efflux in staurosporine-induced apoptosis in colonic epithelial cells.

Authors:  Magdalena L Circu; Sarah Stringer; Carol Ann Rhoads; Mary Pat Moyer; Tak Yee Aw
Journal:  Biochem Pharmacol       Date:  2008-09-17       Impact factor: 5.858

Review 5.  The hidden side of SERPINB1/Leukocyte Elastase Inhibitor.

Authors:  Alicia Torriglia; Elisabeth Martin; Imene Jaadane
Journal:  Semin Cell Dev Biol       Date:  2016-07-12       Impact factor: 7.727

6.  The activation of the atypical PKC zeta in light-induced retinal degeneration and its involvement in L-DNase II control.

Authors:  Imene Jaadane; Sabine Chahory; Chloé Leprêtre; Boubaker Omri; Laurent Jonet; Francine Behar-Cohen; Patricia Crisanti; Alicia Torriglia
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

7.  Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis.

Authors:  Jianghong Wu; Yuren Wang; Shuguang Liang; Haiching Ma
Journal:  Drug Des Devel Ther       Date:  2014-05-24       Impact factor: 4.162

8.  OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis.

Authors:  Miki Takata; Elena Pachera; Mojca Frank-Bertoncelj; Anastasiia Kozlova; Astrid Jüngel; Michael L Whitfield; Shervin Assassi; Maurizio Calcagni; Jeska de Vries-Bouwstra; Tom W Huizinga; Fina Kurreeman; Gabriela Kania; Oliver Distler
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.